3D-Printed Medical Devices: Product Liability and FDA Considerations

Why Additive Manufacturing Can Change the Liability Analysis

A 3D-printed medical device product liability matter may involve more than the finished device. Additive manufacturing, commonly called 3D printing, builds an object layer by layer from a digital design. In a medical-device workflow, relevant questions may extend from source imaging and computer-aided design (CAD) files through software conversion, printing, post-processing, inspection, labeling, and clinical use.

A device may be wholly additively manufactured or include an additively manufactured component. The technology can support complex geometries and patient-matched products, but it also creates a digital-to-physical production record that may matter when an injury is alleged. A change to a source file, software setting, material specification, or printing parameter may warrant technical review, depending on the device and allegations.

The use of additive manufacturing does not itself establish a defect or resolve a claim. Applicable liability standards, defenses, regulatory implications, and evidentiary questions depend on governing law, the device pathway, the parties' roles, and the case-specific record.

Potential Defects and Evidence to Preserve

As with other medical devices, allegations may concern design, manufacturing, warnings or instructions, testing, quality controls, or causation. Potential claims can include design-defect, manufacturing-defect, failure-to-warn, negligence, warranty, or other theories recognized under applicable law. The available claims and defenses vary by jurisdiction and facts.

Early preservation can be especially important because digital manufacturing records may be overwritten, revised, or maintained by separate entities. The finished device alone may not show whether an alleged issue arose in design, printing, post-processing, inspection, packaging, distribution, or use. The relevant record set should be tailored to the allegations and the device's production pathway.

• Design inputs: Examples: Source imaging, CAD files, revision history; Potential question: Did the design change or match specifications?
• Software workflow: Examples: Software versions, conversion logs, build files; Potential question: Did file conversion or version control affect output?
• Materials: Examples: Specifications, lot records, supplier certificates; Potential question: Were specified materials used and documented?
• Production records: Examples: Printer settings, build orientation, machine logs; Potential question: Were production parameters consistent with the process?
• Quality and testing: Examples: Inspection results, deviations, validation records; Potential question: What checks were performed and what did they show?
• Product and use records: Examples: Labeling, warnings, distribution, chain of custody; Potential question: What was provided, and how was the device handled?

Preservation protocols may need to address native files and metadata, access and transfer records, and the handling of any inspection or testing. Where the physical device is available, counsel may also need to document its condition, associated components, storage, and chain of custody before destructive testing or other examination occurs.

Warnings and instructions may be relevant in office-based or decentralized workflows. Records may show whether users received instructions concerning compatible software, file formats, specified printers, materials, processing steps, sterilization, and intended use. The adequacy and legal effect of any warning remain fact- and jurisdiction-dependent.

FDA Considerations and Regulatory Record Review

FDA oversight of an additively manufactured medical device depends on the device, its classification, and its applicable regulatory pathway. Attorneys should review the actual device records, labeling, manufacturing arrangements, and device-specific requirements rather than assume that all 3D-printed devices are regulated alike.

In December 2017, the U.S. Food and Drug Administration issued final guidance, *Technical Considerations for Additive Manufactured Medical Devices*. The guidance addresses technical considerations for devices made entirely through additive manufacturing and devices containing additively manufactured components. Its discussion of design, software workflow, material controls, printing parameters, post-processing, testing, and process validation may help frame document requests and expert analysis.

Guidance should be distinguished from statutes, regulations, and device-specific requirements. FDA states that guidance documents “describe FDA's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.” A departure from guidance does not automatically establish a product defect, negligence, causation, a standard of care, or civil liability.

Federal regulatory context and state-law liability analysis are distinct. For the device at issue, counsel may need to verify its classification and authorization history, applicable quality-system and reporting requirements, design and process validation materials, instructions for use, and the significance of changes to software, materials, or production methods.

Potential Participants and Role-Specific Questions

Additive manufacturing can divide activities that may be more centralized in conventional production. Depending on the facts, relevant participants may include a device designer, manufacturer, printer operator, software provider, material supplier, distributor, healthcare provider, or entity that modified or approved a design.

Responsibility does not follow a universal rule. It may turn on jurisdiction, contractual arrangements, regulatory status, control over design or production, labeling responsibilities, and the allegations pleaded. A useful early assessment identifies who supplied source data, controlled design specifications, selected materials, operated or maintained equipment, approved production steps, performed quality checks, and distributed or clinically implemented the device.

Patient-matched and point-of-care production may require particularly careful factual analysis. A device tailored to a patient's anatomy does not, by itself, determine its regulatory status or whether a particular participant may face liability. The factual inquiry should remain anchored in the actual device pathway and the records available.

Experts in 3D-Printed Medical Device Cases

The appropriate expert disciplines depend on the allegations, technical questions, and available evidence. A case may call for medical-device, biomedical engineering, materials, additive-manufacturing, software, quality-systems, regulatory, imaging, biomechanics, clinical, or causation expertise.

For example, a materials expert may evaluate material identity or performance questions, while an additive-manufacturing expert may assess build parameters, post-processing, and process controls. A software expert may be useful where file conversion, workflow, access controls, or version history is disputed. Regulatory expertise may help organize the applicable FDA record review without substituting for legal analysis.

Expert analysis should remain grounded in the actual device, reliable records, sound methodology, and the disputed legal issues. Early technical review can help attorneys identify evidence gaps, prioritize preservation, and determine whether further inspection or testing is appropriate. If a litigant needs to explain technical device or defect evidence visually at trial, 3D-printed courtroom evidence raises separate demonstrative and evidentiary considerations.